BREAST CANCER MODEL SYSTEMS

摘要

The invention provides cell lines for evaluating therapies for inflammatory breast cancer and triple-negative breast cancer. The cell lines express bioluminescent and/or fluorescent proteins which are used to monitor tumor burden. The cell lines provided by the invention may be used for xenografts.